Key Takeaways
- Three Oklo executivesâCEO Jacob DeWitte, COO Caroline Cochran, and CFO Richard Bealmearâcollectively sold more than $21 million worth of shares on April 1 through pre-scheduled trading plans.
- CEO DeWitte has maintained a pattern of selling shares since January, unloading stock at prices between approximately $50 and $100.
- CNBC’s Jim Cramer expressed skepticism about Oklo’s commercial prospects, stating the company shows “very little prospects for making any money any time in the future.”
- The company’s recent quarterly results fell short of expectations, posting a loss of -$0.27 per share versus analyst estimates of -$0.17.
- Wall Street maintains a “Moderate Buy” rating with a consensus price target of $84.30, though multiple analysts have reduced their targets recently.
On April 1, 2026, Oklo’s executive leadership team executed substantial stock sales totaling more than $21 million, all conducted through previously established Rule 10b5-1 trading arrangements.
Company CEO Jacob DeWitte offloaded shares at weighted average prices spanning $48.41 to $51.20, generating proceeds of $10,069,852. Following this transaction, DeWitte maintains direct ownership of 691,533 Class A shares while controlling over 20 million additional shares through indirect holdings.
Co-founder and COO Caroline Cochran executed sales worth $10,069,852, with share prices falling between approximately $47.99 and $51.79. Her remaining direct stake stands at 658,039 shares.
CFO Richard Bealmear disposed of 16,342 shares priced at $51.08 each, collecting $834,749 from the sale. His current direct holdings total 386,008 Class A shares.
Each executive utilized 10b5-1 trading plans for these transactionsâpredetermined arrangements designed to shield executives from insider trading allegations by establishing sales schedules during periods when material non-public information is not available.
However, DeWitte’s April 1 activity represents merely one chapter in an extended selling campaign. Since January, the CEO has systematically liquidated shares at various price points, including sales near $112, $75, and $63 per share. These cumulative transactions have generated tens of millions in proceeds throughout recent months.
The most recent April 1 saleâcomprising 200,000 shares executed across two separate transactionsâreduced DeWitte’s direct ownership position by 17.58%.
Cramer’s Critical Assessment
The substantial insider selling occurred against a backdrop of harsh criticism from CNBC’s Jim Cramer. Addressing viewer questions about Oklo, Cramer delivered a blunt assessment: “Oklo, while not a science project, has very little prospects for making any money any time in the future that we think is important for a stock.”
This wasn’t Cramer’s first public skepticism toward Oklo. During January commentary, he characterized the company as “not a commercial enterprise,” suggesting that while nuclear energy technology holds promise, established players like GE Vernovaâwhich operate proven commercial systemsâpresent more attractive investment opportunities than Oklo at this stage.
Quarterly Performance and Wall Street Response
From a financial perspective, Oklo delivered disappointing quarterly results, reporting an earnings loss of $0.27 per shareâmissing the Street’s consensus forecast of -$0.17 by a significant $0.10 margin.
Despite continued optimism from many analysts, price targets have experienced notable reductions. UBS lowered its projection from $95 to $60 while maintaining a neutral stance. Needham slashed its target dramatically from $135 to $73, and Canaccord adjusted downward from $175 to $125. Cantor Fitzgerald retained an overweight recommendation with a $122 price objective.
Current Wall Street consensus reflects an average price target of $84.30 with an overall “Moderate Buy” rating. The analyst community breaks down as follows: two Strong Buy ratings, nine Buy ratings, six Hold ratings, and two Sell ratings.
Oklo shares have traded within a 12-month range between $17.42 and $193.84. Technical indicators show the 50-day moving average positioned at $64.62, while the 200-day moving average sits at $93.16.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
